# An Efficacy and Safety Study of Escitalopram Long-Term Treatment in Major Depressive Disorder With Associated Anxiety Symptoms

> **NCT01814098** · PHASE4 · COMPLETED · sponsor: **Xian-Janssen Pharmaceutical Ltd.** · enrollment: 318 (actual)

## Conditions studied

- Depressive Disorder, Major

## Interventions

- **DRUG:** Escitalopram

## Key facts

- **NCT ID:** NCT01814098
- **Lead sponsor:** Xian-Janssen Pharmaceutical Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-07-07
- **Primary completion:** 2011-05-31
- **Final completion:** 2011-11-30
- **Target enrollment:** 318 (ACTUAL)
- **Last updated:** 2017-10-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01814098

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01814098, "An Efficacy and Safety Study of Escitalopram Long-Term Treatment in Major Depressive Disorder With Associated Anxiety Symptoms". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT01814098. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*